Efficacy of telmisartan plus amlodipine in nonresponders to CCB monotherapy

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Neldam, Steen ^a   Zhu, Dingliang ^b   Schumacher, Helmut ^c  

^a Rodovre Centrum 294   (Denmark)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS TELMISARTAN;

BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; MONOTHERAPY; OUTCOME ASSESSMENT; PERIPHERAL EDEMA; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84880174016     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/627938     Document Type: Review

References (37)

1. Ezzati M., Oza S., Danaei G., Murray C. J. L., Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation 2008 117 7 905 914 2-s2.0-39449094835 10.1161/CIRCULATIONAHA.107.732131
2. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M. J., Cifkova R., Clément D., Coca A., Dominiczak A., Erdine S., Fagard R., Farsang C., Grassi G., Haller H., Heagerty A., Kjeldsen S. E., Kiowski W., Mallion J. M., Manolis A., Narkiewicz K., Nilsson P., Olsen M. H., Rahn K. H., Redon J., Rodicio J., Ruilope L., Schmieden R. E., Struijker-Boudier H. A. J., Van Zwieten P. A., Viigimaa M., Zanchetti A., Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. Journal of Hypertension 2009 27 11 2121 2158 2-s2.0-70449851433 10.1097/HJH.0b013e328333146d
3. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L. Jr., Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr., Roccella E. J., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2
4. Mancia G., De B. G., Dominiczak A., Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007 25 6 1105 1187
5. Cushman W. C., Evans G. W., Byington R. P., Goff D. C. Jr., Grimm R. H. Jr., Cutler J. A., Simons-Morton D. G., Basile J. N., Corson M. A., Probstfield J. L., Katz L., Peterson K. A., Friedewald W. T., Buse J. B., Bigger J. T., Gerstein H. C., Ismail-Beigi F., Effects of intensive blood-pressure control in type 2 diabetes mellitus. The New England Journal of Medicine 2010 362 17 1575 1585 2-s2.0-77951735232 10.1056/NEJMoa1001286
6. Denardo S. J., Messerli F. H., Gaxiola E., Aranda J. M. Jr., Cooper-Dehoff R. M., Handberg E. M., Gong Y., Champion A., Zhou Q., Pepine C. J., Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). The American Journal of Cardiology 2010 106 4 498 503 2-s2.0-77955462469 10.1016/j.amjcard.2010.03.056
7. Patel A., MacMahon S., Chalmers J., Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet 2007 370 9590 829 840 2-s2.0-34548420712 10.1016/S0140-6736(07)61303-8
8. Mancia G., Role of outcome trials in providing information on antihypertensive treatment: importance and limitations. The American Journal of Hypertension 2006 19 1 1 7 2-s2.0-32344438818 10.1016/j.amjhyper.2005.10.009
9. Tedesco M. A., Natale F., Calabrò R., Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients. Journal of Clinical Hypertension 2006 8 9 634 641 2-s2.0-34547688084
10. Wald D. S., Law M., Morris J. K., Bestwick J. P., Wald N. J., Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. The American Journal of Medicine 2009 122 3 290 300 2-s2.0-61649091385 10.1016/j.amjmed.2008.09.038
11. Gradman A. H., Basile J. N., Carter B. L., Bakris G. L., Combination therapy in hypertension. Journal of Clinical Hypertension 2011 13 3 146 154 2-s2.0-79952161728 10.1111/j.1751-7176.2010.00397.x
12. National Institute for Health and Clinical Excellence, Hypertension: clinical management of primary hypertension in adults. NICE clinical guidance webpages, 2012, http://guidance.nice.org.uk/CG127
13. Bangalore S., Ley L., Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations. Expert Opinion on Pharmacotherapy 2012 13 3 345 355 2-s2.0-84856287359 10.1517/14656566.2012.652086
14. Bakris G. L., Sarafidis P. A., Weir M. R., Dahlöf B., Pitt B., Jamerson K., Velazquez E. J., Staikos-Byrne L., Kelly R. Y., Shi V., Chiang Y.-T., Weber M. A., Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. The Lancet 2010 375 9721 1173 1181 2-s2.0-77950187294 10.1016/S0140-6736(09)62100-0
15. Micardis, Summary of product characteristics. 2012, http://www.ema. europa.eu/
16. Yusuf S., Teo K. K., Pogue J., Dyal L., Copland I., Schumacher H., Dagenais G., Sleight P., Anderson C., Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England Journal of Medicine 2008 358 15 1547 1559 2-s2.0-42049107348 10.1056/NEJMoa0801317
17. Littlejohn T. W. III, Majul C. R., Olvera R., Results of treatment with telmisartan-amlodipine in hypertensive patients. Journal of Clinical Hypertension 2009 11 4 207 213
18. Littlejohn T. W. III, Majul C. R., Olvera R., Seeber M., Kobe M., Guthrie R., Oigman W., Original research: telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial study. Postgraduate Medicine 2009 121 2 5 14 2-s2.0-64849092873 10.3810/pgm.2009.03. 1972
19. Guthrie R. M., Dahlöf B., Jamerson K. A., Olvera R., Seeber M., Schumacher H., Oigman W., Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients. Current Medical Research and Opinion 2011 27 10 1995 2008 2-s2.0-80052981023 10.1185/03007995.2011.616490
20. Neldam S., Lang M., Jones R., Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. Journal of Clinical Hypertension 2011 13 7 459 466 2-s2.0-79959663642 10.1111/j.1751-7176.2011.00468.x
21. Neutel J., Mancia G., Black H., Single-pill combination of telmisartan 80 Mg/Amlodipine 10 Mg provides superior blood pressure reductions in patients with severe hypertension: teamsta severe Htn study: Ht.1.04. Journal of Hypertension 2010 28 e46
22. Oigman W., Neves M. F., Gismondi R. A., Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results. Expert Review of Cardiovascular Therapy 2010 8 11 1509 1517 2-s2.0-78649390591 10.1586/erc.10.143
23. Sharma A., Bagchi A., Kinagi S. B., Sharma Y. K., Baliga V. P., Bollmall C., Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. Clinical Therapeutics 2007 29 12 2667 2676 2-s2.0-38049014853 10.1016/j.clinthera.2007.12.017
24. White W. B., Littlejohn T. W., Majul C. R., Oigman W., Olvera R., Seeber M., Schumacher H., Mancia G., Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. Blood Pressure Monitoring 2010 15 4 205 212 2-s2.0-77954957139 10.1097/MBP. 0b013e32833c5722
25. Neldam S., Edwards C., Jones R., Switching patients with uncontrolled hypertension on amlodipine 10mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study. Current Medical Research and Opinion 2011 27 11 2145 2153 2-s2.0-80054696302 10.1185/03007995.2011.624089
26. BI Data on file. Study 1235.13. 2012
27. Zhu D., Hu D., Cheng L., Chenglai H., Single-pill combination of telmisartan 80 mg/amlodipine 5 mg provides superior blood pressure reductions on hypertensive patients who fail to respond adequately with amlodipine 5 mg monotherapy. ISH Abstract 698.00 2012 98 supplement 2 10.1136/heartjnl-2012- 302920r.9
28. Mistry N. B., Westheim A. S., Kjeldsen S. E., The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials. Expert Opinion on Pharmacotherapy 2006 7 5 575 581 2-s2.0-33645800765 10.1517/14656566.7.5.575
29. Quan A., Chavanu K., Merkel J., A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies. The American Journal of Cardiovascular Drugs 2006 6 2 103 113 2-s2.0-33645218895 10.2165/00129784- 200606020-00004
30. Sica D. A., Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002 62 3 443 462 2-s2.0-0036189466
31. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 2002 360 9349 1903 1913 2-s2.0-0037079309 10.1016/S0140-6736(02)11911-8
32. Brown M. J., McInnes G. T., Papst C. C., Zhang J., MacDonald T. M., Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. The Lancet 2011 377 9762 312 320 2-s2.0-78751646571 10.1016/S0140-6736(10)62003-X
33. Dahlöf B., Sever P. S., Poulter N. R., Wedel H., Beevers D. G., Caulfield M., Collins R., Kjeldsen S. E., Kristinsson A., McInnes G. T., Mehlsen J., Nieminen M., O'Brien E., Östergren J., Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet 2005 366 9489 895 906 2-s2.0-24644443331 10.1016/S0140-6736(05)67185-1
34. Julius S., Kjeldsen S. E., Weber M., Brunner H. R., Ekman S., Hansson L., Hua T., Laragh J., McInnes G. T., Mitchell L., Plat F., Schork A., Smith B., Zanchetti A., Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. The Lancet 2004 363 9426 2022 2031 2-s2.0-2942635317 10.1016/S0140- 6736(04)16451-9
35. Ofili E. O., Ferdinand K. C., Saunders E., Neutel J. M., Bakris G. L., Cushman W. C., Sowers J. R., Weber M. A., Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. Journal of the National Medical Association 2006 98 4 618 626 2-s2.0-33645656980
36. Weber M. A., Julius S., Kjeldsen S. E., Brunner H. R., Ekman S., Hansson L., Hua T., Laragh J. H., McInnes G. T., Mitchell L., Plat F., Schork M. A., Smith B., Zanchetti A., Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. The Lancet 2004 363 9426 2049 2051 2-s2.0-2942695964 10.1016/S0140-6736(04)16456-8
37. Volpe M., Brommer P., Haag U., Miele C., Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study. Clinical Drug Investigation 2009 29 1 11 25 2-s2.0-57449086215 10.2165/0044011-200929010-00002